Posting of scheme document
March 18 2009 - 5:00AM
UK Regulatory
TIDMGGA
RNS Number : 0195P
Georgica PLC
18 March 2009
Not for release, publication or distribution, in whole or in part, in or into or
from Australia, Canada, Japan, South Africa or the United States or any other
jurisdiction where to do so would constitute a violation of the relevant laws or
regulations of such jurisdiction
18 March
PROPOSED SCHEME OF ARRANGEMENT
to establish
GEORGICA PUBLIC LIMITED COMPANY ("GEORGICA")
as a wholly owned subsidiary of
ESSENDEN PUBLIC LIMITED COMPANY ("ESSENDEN")
to be effected by means of a scheme of arrangement
under part 26 of the Companies Act 2006
and
PROPOSED ADMISSION TO TRADING ON AIM OF THE ENTIRE ISSUED SHARE CAPITAL OF
ESSENDEN
and
PROPOSED ADMISSION TO TRADING ON PLUS-QUOTED OF THE LOAN NOTES TO BE ISSUED BY
ESSENDEN
POSTING OF SCHEME DOCUMENT AND ADMISSION DOCUMENT
On 10 March 2009, the Georgica Board announced its proposal to establish
Georgica as a wholly-owned subsidiary of a newly incorporated holding company,
named Essenden Public Limited Company, by means of a scheme of arrangement under
Part 26 of the Companies Act 2006 (the "Scheme") resulting in shareholders of
Georgica receiving new ordinary shares in Essenden and loan notes to be issued
by Essenden (the "Essenden Notes"), in exchange for their existing ordinary
shares in Georgica (the "Proposal").
The Georgica Board is pleased to announce that, today, a circular, which sets
out, among other things, the full terms and conditions of the Scheme and an
explanatory statement, together with the action to be taken by Georgica's
Shareholders (the "Scheme Document"), will be posted to Georgica Shareholders.
An Admission Document ("Admission) relating the proposed admission of the
Essenden Shares to trading on AIM and the Essenden Notes to trading on
PLUS-quoted will be posted to Georgica Shareholders along with the Scheme
Document.
The Scheme requires and will be conditional upon, the approval of holders of
ordinary shares in Georgica by the passing of a resolution by the requisite
statutory majority at a meeting convened by the Court (the "Court Meeting") and
the passing of certain additional resolutions being passed by the requisite
majorities at a general meeting of Georgica (the "General Meeting").
Notices convening the Court Meeting and the General Meeting to be held at the
Royal Automobile Club, Pall Mall Clubhouse, 89 Pall Mall, London, SW1Y 5HS at,
respectively, 11:00am (or as soon thereafter as the AGM is concluded or
adjourned and 11:15am on 20 April 2009 (or as soon thereafter as the Court
Meeting is concluded or adjourned), are contained in the Scheme Document. Forms
of Proxy for use in connection with both meetings will be posted with the Scheme
Document.
The Georgica Board, which has been advised by Cenkos, unanimously recommends
that Georgica Ordinary Shareholders vote in favour of the resolution to be
proposed at the Court Meeting and that Georgica Ordinary Shareholders and
Georgica Convertible Shareholders vote in favour of the resolution to be
proposed at the General Meeting, as the members of the Georgica Board intend to
do in respect of their own respective beneficial shareholdings in Georgica
which, on 16 March 2009 (being the last practicable date prior to the
publication of this document), amounted in aggregate to 1,791,243 Georgica
Ordinary Shares, representing approximately 1.84 per cent. of the issued
ordinary share capital of Georgica and 1,015,230 Georgica Convertible Shares,
representing approximately 40 per cent. of the total issued Georgica Convertible
Shares.
Georgica has received irrevocable undertakings from Trefick Limited, North
Atlantic Value LLP and the Georgica Convertible Shareholder to vote in favour of
the Scheme at the Court Meeting (in the case of the Georgica Convertible
Shareholder, in respect of the Georgica Ordinary Shares held by it at the Voting
Record Time) and in favour of the Resolutions at the General Meeting. Trefick
Limited holds as at 16 March 2009 (being the last practicable date before the
publication of this document) 20,777,138 Georgica Ordinary Shares representing,
in aggregate, approximately 21.3 per cent. of the issued ordinary share capital
of Georgica and North Atlantic Value LLP holds as at 16 March 2009 (being the
last practicable date before the publication of this document) 27,060,000
Georgica Ordinary Shares representing, in aggregate, approximately 27.8 per
cent. of the issued ordinary share capital of Georgica. The Georgica Convertible
Shareholder holds in aggregate 539,000 Georgica Ordinary Shares and 2,538,075
Georgica Convertible Shares, representing respectively, in aggregate,
approximately 0.6 per cent. of the issued ordinary share capital of Georgica and
100 per cent. of the issued Georgica Convertible Shares.
It is currently expected that:
* the last day of dealings in, and for registration of transfers of, Georgica
shares will be 20 May 2009 and dealings will be suspended from 7:00am on 21 May
2009;
* the Court hearing to sanction the Scheme will be held on 21 May 2009;
* the Scheme will become effective on 22 May 2009; and
* subject also to the Scheme becoming effective and AIM and PLUS-quoted
respectively approving
Admission, it is currently expected that Admission
and cancellation of admission to trading on AIM of the
ordinary shares of
Georgica, will occur at 8:00am on 26 May 2009.
If any of these expected dates change, Georgica will notify shareholders of the
change by issuing an appropriate announcement through a Regulatory Information
Service.
In accordance with Rules 20 and 26 of the AIM Rules for Companies and Rule 5 of
the PLUS Rules for Issuers an electronic copy of the Scheme Document and the
Admission Document has been sent to the London Stock Exchange and will be made
available on Georgica's website. Physical copies of the Scheme Document, the
Admission Document and the documents on display listed in those documents will
be available for inspection during normal business hours at the offices of
Herbert Smith, Exchange House, Primrose Street, London EC2A 2HS.
The Scheme and the Proposal described in this announcement are not subject to
the City Code on Takeovers and Mergers.
Capitalised terms used in this announcement, unless otherwise defined, shall
have the same meaning as given to them in the Scheme Document.
+-----------------------------------------------------+------------------------+
| Enquiries: | |
+-----------------------------------------------------+------------------------+
| Cenkos | Tel: 020 7397 8900 |
| Nomad to Georgica public limited company | |
| Nomad to Essenden public limited company | |
| PLUS Corporate Adviser to Essenden public limited | |
| company | |
| Nicholas Wells | |
| | |
+-----------------------------------------------------+------------------------+
| Georgica plc | Tel: 0207 600 7900 |
| Nicholas Oppenheim | |
+-----------------------------------------------------+------------------------+
Cenkos, which is authorised and regulated in the United Kingdom by the Financial
Services Authority, is acting exclusively for Georgica and no one else in
connection with the Scheme and is acting as Nomad to Essenden in relation to the
proposed admission of the Essenden Shares to trading on AIM and Corporate
Advisor to Essenden in relation to Admission and is not acting for any other
persons and will not be responsible to anyone other than Georgica and Essenden
for providing the protections afforded to customer of Cenkos or advising them on
the Scheme or Admission.
Distribution of announcement and other matters
The information contained in this announcement may not be the same as that
required under the laws of jurisdictions outside England and Wales. The
distribution of this announcement in jurisdictions other than England and Wales
may be restricted by law and therefore persons into whose possession this
announcement comes should inform themselves about and observe such restrictions.
Any failure to comply with the restrictions may constitute a violation of the
securities laws of any such jurisdiction.
This announcement does not constitute an offer to sell or issue, or the
solicitation of an offer to buy or subscribe for, securities in any jurisdiction
in which such offer or solicitation is unlawful.
Securities may not be offered or sold in the United States unless they are
registered under the US Securities Act or are exempt from such registration. The
Essenden Shares will not be registered under the US Securities Act, and will be
issued in the United States pursuant to the Scheme or Admission in reliance on
the exemption from registration provided by Section 3(a)(10) of that Act. In
addition, the Essenden Shares have not been and will not be registered under the
securities laws of any state of the United States, and will be issued in the
United States pursuant to the Scheme or Admission in reliance on available
exemptions from such state law registration requirements. Neither the SEC nor
any US state securities commission has reviewed or approved this document,
Admission, the Scheme, or the issue of the Essenden Shares or the Essenden
Notes, and any representation to the contrary is a criminal offence in the
United States.
Georgica shareholders (whether or not US persons) who are affiliates (as defined
in the US Securities Act) of Essenden or Georgica prior to, and/or become
affiliates of Essenden or Georgica on or after, the implementation of the Scheme
or Admission of the Essenden Shares or the Essenden Notes will be subject to
certain US transfer restrictions relating to the Essenden Shares and the
Essenden.
The Essenden Notes that may be issued pursuant to the Scheme have not been and
will not be registered under the US Securities Act or under the relevant
securities laws of any state or territory or other jurisdiction of the United
States. Accordingly, Essenden Notes may not be offered or sold in the United
States, except in a transaction not subject to, or in reliance on an exemption
from, the registration requirements of the Securities Act and such state
securities laws.
Any Essenden Notes which may be issued pursuant to the Scheme have not been and
will not be registered under the relevant securities laws of Japan and any
relevant clearances and registrations have not been, and will not be, obtained
from the securities commission of any province or territory of Canada. No
prospectus in relation to the Essenden Notes has been, or will be, lodged with,
or registered with, the Australian Securities and Investments Commission, the
Japanese Ministry of Finance or the Companies and Intellectual Property
Registration Office of South Africa. Accordingly, unless otherwise determined by
Essenden and permitted by applicable law and regulation, the Essenden Notes may
not be, offered, sold, resold, transferred, delivered or distributed, directly
or indirectly in or into Canada, Australia, Japan, South Africa or any other
jurisdiction where to do so would violate the laws of that jurisdiction or would
require registration thereof in such jurisdiction.
The statements contained herein are made as at the date of this announcement,
unless some other time is specified in relation to them, and the issue of this
announcement shall not give rise to any implication that there has been no
change in the facts set forth herein since that date. Nothing contained herein
shall be deemed to be a forecast, projection or estimate of the future financial
performances of Georgica or Essenden, except where otherwise stated.
No person has been authorised to make any representations on behalf of Georgica
or Essenden concerning the Scheme which are inconsistent with the statements
contained herein and any such representations, if made, may not be relied upon
as having been so authorised.
This announcement does not constitute a prospectus or prospectus equivalent
document.
No person should construe the contents of this document as legal, financial or
tax advice and should consult their own advisers in connection with the matters
contained herein.
Forward looking statements
This announcement contains statements with respect to the financial condition,
results of operations and business of Georgica and certain plans and objectives
of the Boards of Directors of Georgica and Essenden that are or may be
forward-looking statements. These forward-looking statements can be identified
by the fact that they do not relate only to historical or current facts.
Forward-looking statements often use words such as 'anticipate', 'target', '
expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'will', 'may',
'should', 'would', 'could' or other words of similar meaning. These statements
are based on assumptions and assessments made by the Boards of Directors of
Georgica and Essenden in light of their experience and their perception of
historical trends, current conditions, expected future developments and other
factors they believe appropriate. By their nature, forward-looking statements
involve risk and uncertainty, and the factors described in the context of such
forward-looking statements in this document could cause actual results and
developments to differ materially from those expressed in or implied by such
forward-looking statements.
Should one or more of these risks or uncertainties materialise, or should
underlying assumptions prove incorrect, actual results may vary materially from
those described in this document. Georgica and Essenden assume no obligation to
update or correct the information contained in this announcement.
END
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCGUURPWUPBGRM
Georgica (LSE:GGA)
Historical Stock Chart
From Oct 2024 to Nov 2024
Georgica (LSE:GGA)
Historical Stock Chart
From Nov 2023 to Nov 2024